Literature DB >> 11086103

Stromal cell-derived factor-1-CXC chemokine receptor 4 interactions play a central role in CD4+ T cell accumulation in rheumatoid arthritis synovium.

T Nanki1, K Hayashida, H S El-Gabalawy, S Suson, K Shi, H J Girschick, S Yavuz, P E Lipsky.   

Abstract

Rheumatoid arthritis (RA) is characterized by the accumulation of CD4(+) memory T cells in the inflamed synovium. To address the mechanism, we analyzed chemokine receptor expression and found that the frequency of CXC chemokine receptor (CXCR)4 expressing synovial tissue CD4(+) memory T cells was significantly elevated. CXCR4 expression could be enhanced by IL-15, whereas stromal cell-derived factor (SDF)-1, the ligand of CXCR4, was expressed in the RA synovium and could be increased by CD40 stimulation. SDF-1 stimulated migration of rheumatoid synovial T cells and also inhibited activation-induced apoptosis of T cells. These results indicate that SDF-1-CXCR4 interactions play important roles in CD4(+) memory T cell accumulation in the RA synovium, and emphasize the role of stromal cells in regulating rheumatoid inflammation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11086103     DOI: 10.4049/jimmunol.165.11.6590

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  103 in total

1.  Surface expression of CC- and CXC-chemokine receptors on leucocyte subsets in inflammatory joint diseases.

Authors:  H Brühl; K Wagner; H Kellner; M Schattenkirchner; D Schlöndorff; M Mack
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

Review 2.  Angiogenesis as a target in rheumatoid arthritis.

Authors:  A E Koch
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

Review 3.  Drug discovery research targeting the CXC chemokine receptor 4 (CXCR4).

Authors:  Won-Tak Choi; Srinivas Duggineni; Yan Xu; Ziwei Huang; Jing An
Journal:  J Med Chem       Date:  2011-12-02       Impact factor: 7.446

4.  Ligand-guided optimization of CXCR4 homology models for virtual screening using a multiple chemotype approach.

Authors:  Marco A C Neves; Sérgio Simões; M Luisa Sá e Melo
Journal:  J Comput Aided Mol Des       Date:  2010-10-20       Impact factor: 3.686

5.  Phospholipase cbeta is critical for T cell chemotaxis.

Authors:  Tami L Bach; Qing-Min Chen; Wesley T Kerr; Yanfeng Wang; Lurong Lian; John K Choi; Dianqing Wu; Marcelo G Kazanietz; Gary A Koretzky; Sally Zigmond; Charles S Abrams
Journal:  J Immunol       Date:  2007-08-15       Impact factor: 5.422

Review 6.  Multiple roles of chemokine CXCL12 in the central nervous system: a migration from immunology to neurobiology.

Authors:  Meizhang Li; Richard M Ransohoff
Journal:  Prog Neurobiol       Date:  2007-11-26       Impact factor: 11.685

7.  Prediction of treatment response to adalimumab: a double-blind placebo-controlled study of circulating microRNA in patients with early rheumatoid arthritis.

Authors:  S B Krintel; C Dehlendorff; M L Hetland; K Hørslev-Petersen; K K Andersen; P Junker; J Pødenphant; T Ellingsen; P Ahlquist; H M Lindegaard; A Linauskas; A Schlemmer; M Y Dam; I Hansen; H C Horn; A Jørgensen; J Raun; C G Ammitzbøll; M Østergaard; K Stengaard-Pedersen; J S Johansen
Journal:  Pharmacogenomics J       Date:  2015-05-05       Impact factor: 3.550

8.  Il-1 beta-induced post-transition effect of NF-kappaB provides time-dependent wave of signals for initial phase of intrapostatic inflammation.

Authors:  Eugene V Vykhovanets; Sanjeev Shukla; Gregory T MacLennan; Olena V Vykhovanets; Donald R Bodner; Sanjay Gupta
Journal:  Prostate       Date:  2009-05-01       Impact factor: 4.104

Review 9.  Chemokines in joint disease: the key to inflammation?

Authors:  J J Haringman; J Ludikhuize; P P Tak
Journal:  Ann Rheum Dis       Date:  2004-04-13       Impact factor: 19.103

Review 10.  The role of chemokines in leucocyte-stromal interactions in rheumatoid arthritis.

Authors:  Andrew Filer; Karim Raza; Mike Salmon; Christopher D Buckley
Journal:  Front Biosci       Date:  2008-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.